Change is the 2026-10-09 close against the previous close; the industry change is the equal-weighted average of its stocks. Sub-industry classification is maintained by cibo. Last FY is each company's latest annual report. Net profit is profit attributable to owners of the parent; ROE = net profit / closing equity attributable to owners. Non-HKD statements are converted at ECB reference rates.
Management
NamePosition
再再鼎医药有限公司Executive Director
杜杜莹Executive Director
LJLeon O. Moulder, Jr.Executive Director
JDJohn Diekman Independent Non-Executive Director
RGRichard Gaynor Independent Non-Executive Director
梁梁颖宇Independent Non-Executive Director
WLWilliam Lis Independent Non-Executive Director
SMScott W. Morrison Independent Non-Executive Director
MVMichel Vounatsos Independent Non-Executive Director
PWPeter Wirth Independent Non-Executive Director
Board list from the HKEXnews "List of Directors and their Role and Function", as of 2026-03-05.
About this page
This page shows ZAI LAB (09688) company information, related securities, the price change distribution and in-industry rankings within its sub-industry, and the board of directors. Quotes come from HKEX Daily Quotations, financial metrics from each company's latest annual report, and the director list from HKEXnews.